Deutsche Bank Ag\ Abb Vie Inc. Call Options Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $15,931 - $24,154	-247 Reduced 19.68%	1,008 $77,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $11,273 - $13,553	-179 Reduced 12.48%	1,255 $95,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $54,662 - $69,871	832 Added 138.21%	1,434 $104,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $10,413 - $12,256	135 Added 28.91%	602 $48,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $26,313 - $32,451	338 Added 262.02%	467 $43,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $3,591 - $4,249	-40 Reduced 23.67%	129 $11,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $61,186 - $81,934	-665 Reduced 79.74%	169 $15,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $836,400 - $917,183	-9,339 Reduced 91.8%	834 $80,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $710,584 - $907,635	10,173	10,173 $903,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.